47
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Internalized HIV stigma, ART initiation and HIV‐1 RNA suppression in South Africa: exploring avoidant coping as a longitudinal mediator

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Cross‐sectional evidence suggests that internalized HIV stigma is associated with lower likelihoods of antiretroviral therapy ( ART) initiation and HIV‐1 RNA suppression among people living with HIV ( PLWH). This study examined these associations with longitudinal data spanning the first nine months following HIV diagnosis and explored whether avoidant coping mediates these associations.

          Methods

          Longitudinal data were collected from 398 South African PLWH recruited from testing centres in 2014 to 2015. Self‐report data, including internalized stigma and avoidant coping (denying and distracting oneself from stressors), were collected one week and three months following HIV diagnosis. ART initiation at six months and HIV‐1 RNA at nine months were extracted from the South Africa National Health Laboratory Service database. Two path analyses were estimated, one testing associations between internalized stigma, avoidant coping and ART initiation, and the other testing associations between internalized stigma, avoidant coping and HIV‐1 RNA suppression.

          Results

          Participants were 36 years old, on average, and 63% identified as female, 18% as Zulu and 65% as Xhosa. The two path models fit the data well ( ART initiation outcome: X 2(7) = 8.14, =  0.32; root mean square error of approximation ( RMSEA) = 0.02; comparative fit index (CFI) = 0.92; HIV‐1 RNA suppression outcome: X 2(7)  = 6.58, =  0.47; RMSEA = 0.00; CFI = 1.00). In both models, internalized stigma one week after diagnosis was associated with avoidant coping at three months, controlling for avoidant coping at one week. In turn, avoidant coping at three months was associated with lower likelihood of ART initiation at six months in the first model and lower likelihood of HIV‐1 RNA suppression at nine months in the second model. Significant indirect effects were observed between internalized stigma with ART non‐initiation and unsuppressed HIV‐1 RNA via the mediator of avoidant coping.

          Conclusions

          Internalized stigma experienced soon after HIV diagnosis predicted lower likelihood of ART initiation and HIV‐1 RNA suppression over the first year following HIV diagnosis. Avoidant coping played a role in these associations, suggesting that PLWH who internalize stigma engage in greater avoidant coping, which in turn worsens medication‐ and health‐related outcomes. Interventions are needed to address internalized stigma and avoidant coping soon after HIV diagnosis to enhance treatment efforts during the first year after HIV diagnosis.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward.

          Although stigma is considered a major barrier to effective responses to the HIV/AIDS epidemic, stigma reduction efforts are relegated to the bottom of AIDS programme priorities. The complexity of HIV/AIDS-related stigma is often cited as a primary reason for the limited response to this pervasive phenomenon. In this paper, we systematically review the scientific literature on HIV/AIDS-related stigma to document the current state of research, identify gaps in the available evidence and highlight promising strategies to address stigma. We focus on the following key challenges: defining, measuring and reducing HIV/AIDS-related stigma as well as assessing the impact of stigma on the effectiveness of HIV prevention and treatment programmes. Based on the literature, we conclude by offering a set of recommendations that may represent important next steps in a multifaceted response to stigma in the HIV/AIDS epidemic.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures.

            Recent analyses suggest that lack of clarity in the conceptualization and measurement of HIV stigma at an individual level is a significant barrier to HIV prevention and treatment efforts. In order to address this concern, we articulate a new framework designed to aid in clarifying the conceptualization and measurement of HIV stigma among individuals. The HIV Stigma Framework explores how the stigma of HIV elicits a series of stigma mechanisms, which in turn lead to deleterious outcomes for HIV uninfected and infected people. We then apply this framework to review measures developed to gauge the effect of HIV stigma since the beginning of the epidemic. Finally, we emphasize the utility of using three questions to guide future HIV stigma research: who is affected by, how are they affected by, and what are the outcomes of HIV stigma?
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Current Directions in Mediation Analysis.

              Mediating variables continue to play an important role in psychological theory and research. A mediating variable transmits the effect of an antecedent variable on to a dependent variable, thereby providing more detailed understanding of relations among variables. Methods to assess mediation have been an active area of research for the last two decades. This paper describes the current state of methods to investigate mediating variables.
                Bookmark

                Author and article information

                Contributors
                earnshaw@udel.edu
                Journal
                J Int AIDS Soc
                J Int AIDS Soc
                10.1002/(ISSN)1758-2652
                JIA2
                Journal of the International AIDS Society
                John Wiley and Sons Inc. (Hoboken )
                1758-2652
                26 October 2018
                October 2018
                : 21
                : 10 ( doiID: 10.1002/jia2.2018.21.issue-10 )
                : e25198
                Affiliations
                [ 1 ] Department of Human Development and Family Sciences University of Delaware Newark DE USA
                [ 2 ] RAND Corporation Santa Monica CA USA
                [ 3 ] Department of Psychological & Brain Sciences University of Delaware Newark DE USA
                [ 4 ] Department of Medicine Brigham and Women's Hospital Boston MA USA
                [ 5 ] Harvard Medical School Boston MA USA
                [ 6 ] Southern Africa Labour and Development Research Unit University of Cape Town Rondebosch Cape Town South Africa
                [ 7 ] Perinatal HIV Research Unit Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa
                [ 8 ] Desmond Tutu HIV Centre, IDM and Department of Medicine University of Cape Town Cape Town South Africa
                [ 9 ] South African Medical Research Council Cape Town South Africa
                [ 10 ] Oregon Health & Science University‐Portland State University School of Public Health Portland OR USA
                [ 11 ] Center for Global Health Massachusetts General Hospital Boston MA USA
                [ 12 ] Harvard Global Health Institute Cambridge MA USA
                Author notes
                [*] [* ] Corresponding author: Valerie A Earnshaw, 111 Alison Hall West, Newark, Delaware 19716, USA. Tel: 302 831 4772. ( earnshaw@ 123456udel.edu )
                Author information
                http://orcid.org/0000-0002-4147-3301
                http://orcid.org/0000-0002-6971-3039
                http://orcid.org/0000-0002-7606-8744
                Article
                JIA225198
                10.1002/jia2.25198
                6202800
                30362662
                72189e19-e568-48ce-847e-366a22d4eae0
                © 2018 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 29 May 2018
                : 02 October 2018
                Page count
                Figures: 2, Tables: 2, Pages: 7, Words: 5924
                Funding
                Funded by: National Institutes of Health
                Award ID: K01DA042881
                Award ID: P30MH058107
                Award ID: K23MH110338
                Award ID: K23MH097667
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                jia225198
                October 2018
                Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.5.1 mode:remove_FC converted:26.10.2018

                Infectious disease & Microbiology
                antiretroviral therapy,coping,hiv,south africa,stigma
                Infectious disease & Microbiology
                antiretroviral therapy, coping, hiv, south africa, stigma

                Comments

                Comment on this article